Jie Hong Selected Research

Glipizide (Glucotrol)

11/2017	Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment.
10/2014	Lipid profiling reveals different therapeutic effects of metformin and glipizide in patients with type 2 diabetes and coronary artery disease.
1/2014	Response to comment on Hong et al. Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease. Diabetes care 2013;36:1304-1311.
5/2013	Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jie Hong Research Topics

Disease

35	Neoplasms (Cancer) 01/2021 - 01/2003
29	Colorectal Neoplasms (Colorectal Cancer) 11/2021 - 01/2011
27	Insulin Resistance 12/2021 - 11/2003
23	Obesity 01/2022 - 11/2003
23	Type 2 Diabetes Mellitus (MODY) 12/2021 - 11/2003
17	Carcinogenesis 12/2021 - 01/2011
13	Adenocarcinoma 10/2019 - 02/2010
12	Inflammation (Inflammations) 01/2017 - 06/2006
10	Body Weight (Weight, Body) 01/2022 - 10/2007
10	Stomach Neoplasms (Stomach Cancer) 01/2017 - 09/2012
8	Neoplasm Metastasis (Metastasis) 01/2020 - 09/2014
8	Glucose Intolerance 12/2009 - 11/2003
6	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2020 - 06/2006
6	Coronary Artery Disease (Coronary Atherosclerosis) 10/2014 - 12/2008
5	Weight Loss (Weight Reduction) 07/2021 - 07/2017
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 11/2003
5	Atherosclerosis 09/2014 - 02/2006
4	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 08/2007
3	Necrosis 06/2020 - 06/2013
3	Colonic Neoplasms (Colon Cancer) 11/2019 - 08/2016
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2017 - 07/2012
3	Pneumonia (Pneumonitis) 12/2015 - 06/2014
3	Graves Disease (Basedow Disease) 09/2015 - 01/2013
3	Hypertension (High Blood Pressure) 11/2011 - 10/2009
2	COVID-19 03/2022 - 02/2021
2	Strabismus (Squint) 02/2022 - 02/2022
2	Prediabetic State (Prediabetes) 01/2022 - 01/2020
2	Diabetes Mellitus 01/2021 - 08/2009
2	Hyperglycemia 01/2020 - 08/2008
2	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 10/2019 - 07/2012
2	Hypoxia (Hypoxemia) 01/2019 - 01/2018
2	Melanoma (Melanoma, Malignant) 01/2019 - 09/2006
2	Abdominal Obesity 01/2017 - 10/2010
2	Overweight 01/2016 - 02/2006
2	Autoimmune Diseases (Autoimmune Disease) 03/2015 - 01/2014

Drug/Important Bio-Agent (IBA)

32	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 11/2003
17	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2011
16	Biomarkers (Surrogate Marker)IBA 07/2021 - 01/2013
12	Long Noncoding RNAIBA 11/2021 - 09/2014
10	Insulin (Novolin)FDA Link 10/2017 - 11/2003
8	Triglycerides (Triacylglycerol)IBA 01/2021 - 11/2003
8	EnzymesIBA 01/2021 - 09/2006
8	MicroRNAs (MicroRNA)IBA 01/2019 - 08/2011
7	Messenger RNA (mRNA)IBA 01/2021 - 09/2014
7	CytokinesIBA 01/2020 - 06/2006
6	LipidsIBA 01/2022 - 11/2003
6	Biological ProductsIBA 11/2021 - 11/2013
6	Small Interfering RNA (siRNA)IBA 01/2020 - 06/2006
6	titanium dioxide (Titania)FDA Link 11/2017 - 06/2013
5	RNA (Ribonucleic Acid)IBA 11/2021 - 01/2018
5	Bile Acids and Salts (Bile Acids)IBA 11/2018 - 02/2010
5	AcidsIBA 01/2017 - 07/2009
5	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2016 - 06/2012
5	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2016 - 02/2010
4	Pharmaceutical PreparationsIBA 03/2022 - 01/2011
4	TitaniumIBA 10/2019 - 01/2014
4	Glipizide (Glucotrol)FDA LinkGeneric 11/2017 - 05/2013
4	Metformin (Glucophage)FDA LinkGeneric 10/2017 - 05/2013
4	Dimenhydrinate (DMH)FDA LinkGeneric 10/2015 - 01/2011
4	OsteopontinIBA 09/2015 - 01/2013
3	Glutamic Acid (Glutamate)FDA Link 12/2021 - 06/2016
3	Hormones (Hormone)IBA 01/2021 - 10/2017
3	LigandsIBA 01/2021 - 01/2013
3	CateninsIBA 01/2020 - 06/2014
3	DNA (Deoxyribonucleic Acid)IBA 02/2017 - 01/2003
3	LeptinIBA 01/2017 - 12/2013
3	Histones (Histone)IBA 08/2016 - 02/2012
3	Epidermal Growth Factor (EGF)IBA 01/2016 - 09/2014
3	BerberineIBA 10/2015 - 07/2008
3	HDL CholesterolIBA 03/2015 - 01/2012
3	LDL CholesterolIBA 09/2014 - 02/2006
3	Interleukin-18 (Interleukin 18)IBA 06/2010 - 06/2006
3	AdiponectinIBA 12/2008 - 06/2006
2	Glutamine (L-Glutamine)FDA Link 12/2021 - 06/2016
2	Peptides (Polypeptides)IBA 01/2021 - 11/2010
2	Indicators and Reagents (Reagents)IBA 01/2021 - 02/2006
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021 - 01/2018
2	SteroidsIBA 01/2020 - 10/2017
2	Blood Glucose (Blood Sugar)IBA 01/2020 - 09/2005
2	HLA Antigens (Human Leukocyte Antigens)IBA 10/2019 - 07/2016
2	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2018 - 03/2014
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 05/2017 - 08/2009
2	AlbuminsIBA 05/2017 - 12/2008
2	Gonadal Steroid Hormones (Sex Hormones)IBA 04/2017 - 08/2008
2	Sex Hormone-Binding GlobulinIBA 04/2017 - 08/2008
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2017 - 01/2015
2	GlucocorticoidsIBA 01/2017 - 12/2012
2	InterleukinsIBA 08/2016 - 06/2006
2	ThymidineIBA 08/2016 - 02/2013
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2015 - 10/2010
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2015 - 09/2014
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2015 - 06/2014
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 12/2015 - 09/2014
2	1,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA 10/2015 - 01/2015
2	CC ChemokinesIBA 09/2015 - 01/2013

Therapy/Procedure

10	Therapeutics 12/2021 - 09/2006
3	Drug Therapy (Chemotherapy) 02/2021 - 07/2017
3	Bariatric Surgery 01/2021 - 07/2017
2	Glycemic Control 11/2020 - 10/2007
2	Hematopoietic Stem Cell Transplantation 01/2017 - 07/2012